TABLE 4.
Linezolid group* | Vancomycin IV Group* | |||||
---|---|---|---|---|---|---|
Sensititvity analysis | Hospital cost | Nonhospital cost | Total cost | Hospital cost | Nonhospital cost | Total cost |
Conservative switch therapy eligibility for linezolid group | $7,694 | $442 | $8,136 | $7,846 | $597 | $8,444 |
No early discharge eligibility for linezolid patients | $8,462 | $316 | $8,778 | $7,846 | $597 | $8,444 |
Increased hospitalization cost ($1,002/day) | $17,326 | $442 | $17,768 | $18,324 | $597 | $18,921 |
Decreased hospital anti-infective costs (-20%) | $7,505 | $442 | $7,947 | $7,744 | $597 | $8,342 |
Increased hospital anti-infective costs (20%) | $7,882 | $442 | $8,325 | $7,948 | $597 | $8,545 |
Costs expressed as cost per patient. IV Intravenous